Bernhard Sixt
Directeur Général chez ImmunID SAS
Profil
Bernhard Sixt was the founder of Agendia NV, founded in 2003, where he held the title of Chief Executive Officer.
He was also the founder of Agendia, Inc., founded in 2003, where he held the title of Chief Executive Officer from 2010 to 2011.
Currently, he is the Chairman & Chief Executive Officer of ImmunID SAS since 2013 and the Chief Executive Officer of Edinburgh Molecular Imaging Ltd.
since 2018.
In the past, he worked as the Director-Global Strategic Marketing Oncology at GE Healthcare Buchler GmbH & Co. KG and as a Principal at Nycomed GmbH.
Dr. Sixt holds a doctorate degree from Technische Universität München and a graduate degree from Ludwig-Maximilians-Universität München.
Postes actifs de Bernhard Sixt
| Sociétés | Poste | Début |
|---|---|---|
ImmunID SAS
 ImmunID SAS Medical SpecialtiesHealth Technology ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France. | Directeur Général | 24/07/2013 |
Edinburgh Molecular Imaging Ltd.
 Edinburgh Molecular Imaging Ltd. Medical SpecialtiesHealth Technology Edinburgh Molecular Imaging Ltd. develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging. The firm's molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue. The company was founded by Chris Haslett, Kev Dhaliwal and Mark Bradley in February 2014 and is headquartered in Edinburgh, the United Kingdom. | Directeur Général | 08/11/2018 |
Anciens postes connus de Bernhard Sixt
| Sociétés | Poste | Fin |
|---|---|---|
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Directeur Général | 24/10/2011 |
| Nycomed GmbH | Corporate Officer/Principal | - |
GE Healthcare Buchler GmbH & Co. KG
 GE Healthcare Buchler GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Founded in 1971, GE Healthcare Buchler GmbH & Co. KG is a German pharmaceutical manufacturing company. Part of General Electric Co., the company is based in Braunschweig, Germany. | Sales & Marketing | - |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Directeur Général | - |
Formation de Bernhard Sixt
| Technische Universität München | Doctorate Degree |
| Ludwig-Maximilians-Universität München | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
ImmunID SAS
ImmunID SAS Medical SpecialtiesHealth Technology ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France. | Health Technology |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
| Nycomed GmbH | |
GE Healthcare Buchler GmbH & Co. KG
GE Healthcare Buchler GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Founded in 1971, GE Healthcare Buchler GmbH & Co. KG is a German pharmaceutical manufacturing company. Part of General Electric Co., the company is based in Braunschweig, Germany. | Health Technology |
Edinburgh Molecular Imaging Ltd.
Edinburgh Molecular Imaging Ltd. Medical SpecialtiesHealth Technology Edinburgh Molecular Imaging Ltd. develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging. The firm's molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue. The company was founded by Chris Haslett, Kev Dhaliwal and Mark Bradley in February 2014 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |